| __timestamp | ACADIA Pharmaceuticals Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 5496000 |
| Thursday, January 1, 2015 | 90804000 | 9786000 |
| Friday, January 1, 2016 | 186456000 | 6792000 |
| Sunday, January 1, 2017 | 255062000 | 7313000 |
| Monday, January 1, 2018 | 265758000 | 8382000 |
| Tuesday, January 1, 2019 | 325638000 | 10803000 |
| Wednesday, January 1, 2020 | 388661000 | 12944000 |
| Friday, January 1, 2021 | 396028000 | 21967000 |
| Saturday, January 1, 2022 | 369090000 | 32810000 |
| Sunday, January 1, 2023 | 402466000 | 46542000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, ACADIA Pharmaceuticals Inc. and Xenon Pharmaceuticals Inc. have taken different paths in optimizing these costs. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking at approximately $402 million in 2023. In contrast, Xenon maintained a more conservative growth, with expenses increasing by around 750% to nearly $47 million in the same period.
This stark difference highlights ACADIA's aggressive expansion strategy, while Xenon appears to focus on lean operations. The data suggests that ACADIA's approach may be driven by a need to support rapid growth and market penetration, whereas Xenon prioritizes cost efficiency. As the pharmaceutical landscape evolves, these strategies will undoubtedly shape their competitive positions.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends